Tax rules that killed Allergan-Pfizer deal may be hard to challenge
Go back to Tax rules that killed Allergan-Pfizer deal may be hard to challenge| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.07 +0.28 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.77 | 52 Week Low | $28.25 | |||
| Day High | $28.43 | P/E | 17.01 | |||
| Day Low | $27.66 | EPS | $1.65 | |||
| Volume | 36,712,585 | |||||
